(function(){var loadHandler=window['sl_{72C0429F-FC8A-44E7-B152-D6826999A52C}'];loadHandler&&loadHandler(108, '<div id="spr0_42c19a0c"><div id="spr1_42c19a0c" class="kern slide"><img id="img1_42c19a0c" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_42c19a0c" class="kern slide"><div id="spr3_42c19a0c" style="left:20.727px;top:202.34px;"><div id="spr4_42c19a0c"><img id="img0_42c19a0c" src="data/img114.png" width="680.042" height="192.744" alt=""/></div><div id="spr5_42c19a0c" style="top:0px;"><div style="width:0px;"><span id="txt0_42c19a0c" data-width="86.578125" style="left:7.2px;top:14.964px;">Inhibitor</span></div></div><div id="spr6_42c19a0c" style="left:137.452px;top:0px;"><div style="width:0px;"><span id="txt1_42c19a0c" data-width="136.277344" style="left:9.555px;top:0.564px;">Neo-adjuvant</span></div><div style="width:0px;"><span id="txt2_42c19a0c" data-width="101.906250" style="left:26.75px;top:29.364px;">treatment</span></div></div><div id="spr7_42c19a0c" style="left:292.359px;top:0px;"><div style="width:0px;"><span id="txt3_42c19a0c" data-width="192.093750" style="left:12.85px;top:0.564px;">Early Breast Cancer</span></div><div style="width:0px;"><span id="txt4_42c19a0c" data-width="198.164063" style="left:10.005px;top:29.364px;">Adjuvant treatment</span></div></div><div id="spr8_42c19a0c" style="left:509.452px;top:0px;"><div style="width:0px;"><span id="txt5_42c19a0c" data-width="98.507813" style="left:35.468px;top:0.564px;">Advanced</span></div><div style="width:0px;"><span id="txt6_42c19a0c" data-width="134.085938" style="left:17.823px;top:29.364px;">breast cancer</span></div></div><div id="spr9_42c19a0c" style="top:64.8px;"><div style="width:0px;"><span id="txt7_42c19a0c" data-width="116.027344" style="left:7.2px;top:0.564px;">Anastrozole</span></div></div><div id="spr10_42c19a0c" style="left:137.452px;top:64.8px;"><div style="width:0px;"><span id="txt8_42c19a0c" data-width="77.343750" style="left:39.745px;top:0.564px;">IMPACT</span></div></div><div id="spr11_42c19a0c" style="left:292.361px;top:64.8px;"><div style="width:0px;"><span id="txt9_42c19a0c" data-width="52.265625" style="left:84.383px;top:0.564px;">ATAC</span></div></div><div id="spr12_42c19a0c" style="left:509.452px;top:64.8px;"><div style="width:0px;"><span id="txt10_42c19a0c" data-width="77.167969" style="left:46.971px;top:0.564px;">TARGET</span></div></div><div id="spr13_42c19a0c" style="top:100.8px;"><div style="width:0px;"><span id="txt11_42c19a0c" data-width="118.640625" style="left:7.2px;top:10.164px;">Exemestane</span></div></div><div id="spr14_42c19a0c" style="left:137.452px;top:100.8px;"><div style="width:0px;"><span id="txt12_42c19a0c" data-width="130.634766" style="left:12.335px;top:1.07px;">Semiglazov et al</span></div><div style="width:0px;"><span id="txt13_42c19a0c" data-width="40.546875" style="left:57.205px;top:25.07px;">2005</span></div></div><div id="spr15_42c19a0c" style="left:292.361px;top:100.8px;"><div style="width:0px;"><span id="txt14_42c19a0c" data-width="57.820313" style="left:79.738px;top:10.164px;">TEAM</span></div></div><div id="spr16_42c19a0c" style="left:509.452px;top:100.8px;"><div style="width:0px;"><span id="txt15_42c19a0c" class="relpos" data-width="70.558594" style="left:19.533px;top:10.164px;">EORTC </span><span id="txt16_42c19a0c" class="relpos" data-width="60.820313" style="left:19.528px;top:10.164px;">10951</span></div></div><div id="spr17_42c19a0c" style="top:156px;"><div style="width:0px;"><span id="txt17_42c19a0c" data-width="90.679688" style="left:7.2px;top:0.564px;">Letrozole</span></div></div><div id="spr18_42c19a0c" style="left:137.452px;top:156px;"><div style="width:0px;"><span id="txt18_42c19a0c" data-width="54.316406" style="left:50.392px;top:0.564px;">P 024</span></div></div><div id="spr19_42c19a0c" style="left:292.361px;top:156px;"><div style="width:0px;"><span id="txt19_42c19a0c" data-width="83.507813" style="left:66.92px;top:0.564px;">BIG 1-98</span></div></div><div id="spr20_42c19a0c" style="left:509.452px;top:156px;"><div style="width:0px;"><span id="txt20_42c19a0c" data-width="54.316406" style="left:57.483px;top:0.564px;">P 025</span></div></div></div><div id="spr21_42c19a0c" style="top:3.651px;"><div style="width:0px;"><span id="txt21_42c19a0c" data-width="288.763672" style="left:111.918px;top:0.058px;">Selected trials confirming</span></div><div style="width:0px;"><span id="txt22_42c19a0c" data-width="311.226563" style="left:101.488px;top:33.658px;">superiority of AIs over TAM</span></div></div><div id="spr22_42c19a0c" style="top:104.734px;"><div style="width:0px;"><span id="txt23_42c19a0c" data-width="261.980469" style="left:229.375px;top:0.058px;">Post-menopause only !</span></div></div><div id="spr23_42c19a0c" style="left:-0px;top:145.932px;"><div style="width:0px;"><span id="txt24_42c19a0c" data-width="265.634766" style="left:227.598px;top:1.07px;">Only ER+ve patients, of course …</span></div></div><div id="spr24_42c19a0c" style="left:-0px;top:426.083px;"><div style="width:0px;"><span id="txt25_42c19a0c" data-width="629.179688" style="left:45.762px;top:1.07px;">These are just a small fraction of trials in endocrine treatment and resistance.</span></div><div style="width:0px;"><span id="txt26_42c19a0c" data-width="631.640625" style="left:45.482px;top:25.07px;">There are many more completed and on-going: phase I, II, III, post-approval …</span></div><div style="width:0px;"><span id="txt27_42c19a0c" data-width="576.894531" style="left:73.688px;top:49.07px;">Focused on treatment efficacy, tolerability, combination, sequencing …</span></div></div></div></div>');})();